As the end of the year draws nears, we would like to thank our members, sponsors, partners, and many volunteers for their participation and contributions. With this help, we had a very productive year. In particular, we co-organized two Symposia in 2021, and launched our Career Shorts interviews and webinar series on Antibody Discovery & Development, Commercializing Antibody Therapeutics, and Adaptive Immune Receptor Repertoires.
In case you missed either Symposia, recordings from our Emerging Immunotherapeutics for Ovarian Cancer Symposium (co-organized with the Ovarian Cancer Research Alliance) and Emerging Cancer Therapies Leveraging Gamma-Delta Effector T cells Symposium (co-organized with LAVA Therapeutics) are available On Demand on our YouTube channel.
The Career Shorts interviews are also available on our YouTube channel. In this series, scientists and individuals working within the world of antibodies discuss the experiences that have shaped their careers. In sharing their experiences and advice, we aim to empower the next generation of scientists and leaders working in this field to make confident and informed decisions. Career Shorts is the creation of an exceptionally talented volunteer, Raquel Barroso Ferro.
We hope you will join us in our activities in 2022. In particular, The Adaptive Immune Receptor Repertoire (AIRR) Community of The Antibody Society will hold their 6th meeting during May 16-19, 2022. The “Exploring New Frontiers” meeting will be held in person in La Jolla, CA. The AIRR Community is a research-driven group that is organizing and coordinating stakeholders in the use of next-generation sequencing technologies to study antibody/B-cell and T-cell receptor repertoires.
Our volunteer experts in antibody engineering, Drs. Alicia Chenoweth and Silvia Crescioli, will apply their formidable knowledge of this area to create a searchable table of antibody therapeutics in late-stage clinical studies that will appear online in Q1 2022. Their very useful searchable table of antibody therapeutics that are approved or in review in the European Union or United States is already online.
In addition, we are planning a Symposium on Biopharmaceutical Informatics, tentatively scheduled for September 2022, and we will start a new Graduate Student/Post-doc Research Competition. When available, details for these new programs will be posted on our website and sent via email to members.
